Tag Archives: POLICY

A New Addition to Pennsylvania Bio’s Leadership Team

ct-115x76

To effectively achieve our mission as the champion and advocate of biotechnology, BIO works with a broad network of organizations. Foremost among these relationships are the ones we possess with a broad network of state-based organizations known as the Council of State Bioscience Associations (CSBA). Pennsylvania Bio (PA Bio) has been a key ally to BIO and vocal advocate for state and federal public policy in support of the biotechnology industry since our inception. Just Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

TTIP: Global Regulatory Cooperation and Convergence

Moving Inside the Beltway: Brief Health Roundup

The Transatlantic Trade and Investment Partnership (TTIP) initiative holds tremendous promise for the long-term competitiveness of the Transatlantic economy by supporting research and development of innovative technologies. A concerted effort through the TTIP to unleash the potential of biotechnology in the Transatlantic economy can help bring innovative products to consumers, create jobs, and improve economic prospects on both sides of the Atlantic. The recent (TTIP) negotiations focus on several principles that BIO promotes to boost Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

“The Technology is Here, It’s Ready”

Refinery

Last week the Milken Institute, a nonpartisan economic think tank, released a Financial Innovations Lab Report: Unleashing the Power of the Bio-Economy. The Milken Institute hosted a Financial Innovations Lab on industrial biotech in April of 2012 to explore ideas to spur the industry, bringing together leading scientists, senior government officials, industry executives, institutional investors and venture capitalists. Tremendous potential for economic and environmental benefits exist with using biobased chemicals instead of petrochemicals. Thanks to Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , ,

How Countries Can Boost Their Biotech Industry

Field

How can countries and regions boost the biotech industry within their borders? Working with several member companies, BIO developed a Global Policy Platform to serve as a roadmap for policymakers seeking to create an environment for the biotech industry to grow and prosper. These policy principles include four components: (i) research collaboration; (ii) intellectual property rights; (iii) regulatory approval; and (iv) market access. In addition, the Global Policy Platform includes best practices from around the Read More >

Corporate  |  1 Comment  |  Email This Post
Tags: , , , ,

Effective Tax Rates for Biotech

The New York Times published a misleading article and companion blog post on corporate tax rates last Thursday, leaving us scratching our heads over the claim that the biotech sector pays a paltry “effective” corporate tax rate of 4.46%, the lowest rate amongst the 20 industries surveyed.  After careful reading of the article and examination of supporting documents, we found that the authors vastly underestimated the industry’s effective tax rate. First, the authors incorrectly average Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,